MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma.

Nasopharyngeal cancer (NPC) is an endemic type of head and neck cancer with a high rate of cervical lymph node metastasis. An increasing number of studies have shown that microRNAs (miRNAs) play a key role in the development and progression of NPC. miR-338-3p has been demonstrated as an anti-oncogene in different solid tumors. The aim of the present study was to investigate the potential role of miR‑338-3p in the development and progression of NPC. Compared with normal samples, our data showed that miR-338-3p were downregulated in NPC tissues and cells. The luciferase assay demonstrated that HIF-1α was a direct target of miR-338-3p. We also found that miR-338-3p regulated the expression levels of HIF-1α, respectively. Overexpression of miR-338-3p in NPC cells significantly inhibited cell proliferation, and migration. Conversely, miR-338-3p knockdown in cells with lower endogenous expression levels significantly reduced antitumor behavior. Furthermore, enforced expression of miR-338-3p led to a decline in ERK phosphorylation as well as inhibited the hypoxia induced epithelial to mesenchymal transition. Cells pre-transfected with miR-338-3p can overcome hypoxia-mediated cisplatin resistance. Taken together, we found that miR-338-3p directly targeted HIF-1α, and we provide insight into NPC initiation and progression, possibly representing a novel therapeutic target.

[1]  N. Raulf,et al.  MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance , 2015, International journal of cancer.

[2]  Ming-hua Bai,et al.  Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo , 2015, Neuropharmacology.

[3]  H. Olschewski,et al.  Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization , 2015, Molecular Cancer.

[4]  Liang Zhao,et al.  MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α , 2014, PloS one.

[5]  Yuhan Chen,et al.  Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosis , 2014, Medical Oncology.

[6]  Lungen Lu,et al.  MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia‑inducible factor-2α pathway in vitro and in vivo. , 2014, Molecular medicine reports.

[7]  Ying Huang,et al.  Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells. , 2014, International journal of molecular medicine.

[8]  T. Ng,et al.  Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. , 2014, Biochemical pharmacology.

[9]  Yang Peng,et al.  MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression , 2014, PloS one.

[10]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[11]  S. Kondo,et al.  Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes , 2014, Oncogene.

[12]  C. Jiang,et al.  Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells. , 2014, International journal of molecular medicine.

[13]  L. Pfeffer,et al.  MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers , 2014, Breast Cancer Research.

[14]  Zong-fang Li,et al.  Insidious Changes in Stromal Matrix Fuel Cancer Progression , 2014, Molecular Cancer Research.

[15]  Ying Sun,et al.  MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma , 2013, Molecular Cancer.

[16]  M. Ringnér,et al.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development , 2013, Proceedings of the National Academy of Sciences.

[17]  Hai-Jun Deng,et al.  miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. , 2013, World journal of gastroenterology.

[18]  Jia Liu,et al.  Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma , 2013, BMC Cancer.

[19]  Ying Sun,et al.  MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. , 2013, Cancer letters.

[20]  Y. Zeng,et al.  MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. , 2013, Cancer letters.

[21]  Xiaoling Li,et al.  miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. , 2013, Carcinogenesis.

[22]  B. Bao,et al.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. , 2012, Biochimica et biophysica acta.

[23]  J. Bussink,et al.  Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy , 2012, Clinical Cancer Research.

[24]  M. Michael,et al.  Hypoxic enhancement of exosome release by breast cancer cells , 2012, BMC Cancer.

[25]  Hanmin Wang,et al.  Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells , 2012, PloS one.

[26]  D. Fan,et al.  Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. , 2011, Biochemical and biophysical research communications.

[27]  Jing-Song Chen,et al.  miR‐338‐3p suppresses invasion of liver cancer cell by targeting smoothened , 2011, The Journal of pathology.

[28]  Xiaoling Li,et al.  miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma , 2011, Journal of Cell Science.

[29]  A. Hui,et al.  MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. , 2011, Cancer research.

[30]  Lu Wang,et al.  MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. , 2011, Cancer research.

[31]  Q. Pan,et al.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. , 2010, Cancer letters.

[32]  Johan Hansson,et al.  MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. , 2010, The Journal of investigative dermatology.

[33]  I. Leav,et al.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. , 2010, Cancer cell.

[34]  M. Zhou,et al.  microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. , 2010, Carcinogenesis.

[35]  Yonghong He,et al.  MiRNA‐26b regulates the expression of cyclooxygenase‐2 in desferrioxamine‐treated CNE cells , 2010, FEBS letters.

[36]  X. Bian,et al.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. , 2010, Biochemical and biophysical research communications.

[37]  G. Song,et al.  Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.

[38]  Qian Wang,et al.  Bead‐based microarray analysis of microRNA expression in hepatocellular carcinoma: miR‐338 is downregulated , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[39]  Chaosu Hu,et al.  Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[40]  T. Osaki,et al.  The involvement of hypoxia‐inducible factor‐1α in the susceptibility to γ‐rays and chemotherapeutic drugs of oral squamous cell carcinoma cells , 2007 .

[41]  T. Osaki,et al.  The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells. , 2007, International journal of cancer.

[42]  H. Schluesener,et al.  Nanovesicular vaccines: exosomes. , 2005, Archivum immunologiae et therapiae experimentalis.

[43]  A. Harris,et al.  Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.